Arterial events in persons with dermatomyositis and polymyositis

Journal of Rheumatology

Volumn 36, Issue 9, 2009, Pages 1943-1946

  Tisseverasinghe, Annaliese ^a   Bernatsky, Sasha ^b,c   Pineau, Christian A ^b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Arterial events; Dermatomyositis; Dyslipidemia; Hypertension; Polymyositis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIMALARIAL AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; METHOTREXATE; WARFARIN;

ADULT; ARTERY DISEASE; ARTICLE; ASSOCIATION; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONTROLLED STUDY; DERMATOMYOSITIS; DRUG EFFECT; DRUG EXPOSURE; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POLYMYOSITIS; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION;

CASE-CONTROL STUDIES; COHORT STUDIES; DERMATOMYOSITIS; DYSLIPIDEMIAS; HUMANS; HYPERTENSION; IMMUNOLOGIC FACTORS; INCIDENCE; LIPID METABOLISM DISORDERS; MYOCARDIAL ISCHEMIA; PERIPHERAL VASCULAR DISEASES; POLYMYOSITIS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; STROKE;

EID: 70349258020     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090061     Document Type: Article

References (14)

1. Blais L, Cyr M-C, Bérard A, et al. Optimal use of drugs: construction of a database for residents of Quebec who have a private insurance drug plan (on-line report). 2004. [Internet. Accessed June 17, 2009.] Available from: http://medpop.qc.ca/en/remed.php
2. The changing face of heart disease and stroke in Canada 2000. Ottawa: Heart and Stroke Foundation of Canada; 1999.
3. Lundberg IE. The heart in dermatomyositis and polymyositis. Rheumatology 2006;45 Suppl:iv18-21.
4. Jeerakathil T, Johnson JA, Simpson SH, Majumdar SR. Short-term risk for stroke is doubled in persons with newly treated type 2 diabetes compared with persons without diabetes: a population-based cohort study. Stroke 2007;38:1739-1743 (Pubitemid 46847242)
5. Suissa S, Bernatsky S, Hudson M. Antirheumatic drug use and the risk of acute myocardial infarction. Arthritis Rheum 2006;55:531-536 (Pubitemid 44289870)
6. Solomon DH, Goodson NJ, Katz JN, et al. Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis 2006;65:1608-1612 (Pubitemid 44799673)
7. Petri M, Lakatta C, Magder L, Goldman D. Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. Am J Med 1994;96:254-259 (Pubitemid 24099225)
8. Doria A, Shoenfeld Y, Wu R, et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2003;62:1071-1077 (Pubitemid 37323571)
9. Tanay A, Leibovitz E, Frayman A, Zimlichman R, Shargorodsky M, Gavish D. Vascular elasticity of systemic lupus erythematosus patients is associated with steroids and hydroxychloroquine treatment. Ann NY Acad Sci 2007;1108:24-34. (Pubitemid 47528715)
10. Naranjo A, Sokka T, Descalzo MA, et al. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther 2008;10:R30.
11. Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399-2406 (Pubitemid 37542988)
12. Boers M, Nurmohamed MT, Doelman CJ, et al. Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. Ann Rheum Dis 2003;62:842-845 (Pubitemid 37026494)
13. Hux JE, Ivis F, Flintoft V, Bica A. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002;25:512-516 (Pubitemid 41103345)
14. Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Senecal JL. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore) 2005;84:231-249 (Pubitemid 41026298)